NCT02482428View on ClinicalTrials.gov

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
External Genital Warts
Interventions
DRUG

Investigational Treatment

Applied twice daily for up to 12 weeks

DRUG

Aldara

Applied 3 times a week for 16 weeks

Trial Locations (1)

60005

Novartis Investigative Site, Arlington Heights

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY